Stockscreener 앱 받기
438.92
2.36%
-10.61
시장 영업 전:
438.07
-0.85
-0.19%
Vertex Pharmaceuticals Inc 주식(VRTX)의 최신 뉴스
Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: Here's Why - Nasdaq
Stock Market Today, Jan. 15: ImmunityBio Surges After Anktiva Revenue Jumps 700% - The Motley Fool
Meritage Portfolio Management Decreases Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Manning & Napier Advisors LLC Purchases 241,242 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Here's what to expect from Vertex Pharmaceuticals' next earnings report - MSN
Vertex Pharmaceuticals Incorporated $VRTX Shares Purchased by Nordea Investment Management AB - MarketBeat
What is Vertex Pharmaceuticals Incorporated s debt to equity ratio2025 Key Highlights & Risk Adjusted Swing Trade Ideas - bollywoodhelpline.com
Vertex Pharmaceuticals Targets Five Product Launches in Five Years Across Diverse Disease Areas - geneonline.com
JPM26: Vertex hopes to match cystic fibrosis success in pain and kidney disease - Pharmaceutical Technology
Here's What to Expect From Vertex Pharmaceuticals' Next Earnings Report - Barchart.com
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Emerges as a Prime GARP Investment Candidate - Chartmill
Sumitomo Mitsui Trust Group Inc. Acquires 45,623 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
VRTX: Strong growth in CF, pain, and renal, with five launches in five years and $12B revenue guidance - TradingView — Track All Markets
Bernstein Upgrades Vertex Pharmaceuticals (VRTX) - Nasdaq
How Is The Market Feeling About Vertex Pharmaceuticals Inc? - Benzinga
Bernstein upgrades Vertex ahead of key renal trial readouts By Investing.com - Investing.com India
Will Vertex (VRTX) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Vertex Pharma Is Quietly Exploding – Here’s What Wall Street Isn’t Telling You - AD HOC NEWS
Here’s What Lifted Vertex Pharmaceuticals (VRTX) in Q4 - Insider Monkey
Loring Wolcott & Coolidge Fiduciary Advisors LLP MA Increases Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
AbbVie buys into PD-1/VEGF sweepstakes; Alnylam and Vertex set expectations - Yahoo Finance
Hardman Johnston Global Advisors LLC Decreases Stake in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
First Horizon Corp Purchases New Shares in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Citizens Financial Group Inc. RI Acquires 9,963 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor MeetingsJanuary 11, 2026 - BioSpace
Vertex Pharmaceuticals Incorporated : Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings - marketscreener.com
New York State Teachers Retirement System Grows Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
The Best Stocks to Invest $50,000 in Right Now - Finviz
Spire Wealth Management Sells 8,962 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Parnassus Investments LLC Lowers Stock Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Sumitomo Mitsui DS Asset Management Company Ltd Has $21.54 Million Stake in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Nisa Investment Advisors LLC Has $21.85 Million Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Oregon Public Employees Retirement Fund Raises Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
What dividend safety score for Vertex Pharmaceuticals Incorporated stockGlobal Markets & Weekly High Conviction Ideas - ulpravda.ru
How The Vertex Pharmaceuticals (VRTX) Story Is Shifting With New Analyst Targets And CF Outlook - Yahoo Finance
Insider Sell: Ourania Tatsis Sells 4,500 Shares of Vertex Pharma - GuruFocus
Vertex Pharmaceuticals (VRTX) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Vertex Pharmaceuticals (NASDAQ:VRTX) EVP Ourania Tatsis Sells 4,500 Shares - MarketBeat
Vertex Pharmaceuticals Officer Sells 4,500 Shares - TradingView — Track All Markets
Does Vertex Pharmaceuticals (VRTX) Share Price Reflect Its Long Term Growth Potential? - Yahoo Finance
Assessing Vertex Pharmaceuticals (VRTX) Valuation After Wolfe Research Upgrade And Growing Pipeline Optimism - Yahoo Finance
Prediction: 2 Healthcare Stocks That Will Be Worth More Than Pfizer by the End of 2026 - Finviz
State of Alaska Department of Revenue Has $14.04 Million Stake in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Joseph Group Capital Management Acquires 2,608 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharma stock: Quiet chart, loud pipeline as Wall Street leans bullish - AD HOC NEWS
SG Americas Securities LLC Has $23.52 Million Stock Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Incorporated (VRTX) is attracting investor attention: Here is what you should know - MSN
Duncker Streett & Co. Inc. Has $922,000 Stake in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex responds to NHS England's counter-offer on access to cystic fibrosis drugs - The Pharma Letter
Wagner, Vertex Pharmaceuticals evp, sells $4.39m in VRTX stock By Investing.com - Investing.com Australia
Why Vertex Pharmaceuticals Incorporated stock could outperform in 2025 - ulpravda.ru
Vertex Pharmaceuticals (VRTX) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance
Vertex Pharmaceuticals (NASDAQ:VRTX) EVP Charles Wagner Jr Sells 9,532 Shares of Stock - MarketBeat
Big Money Moves: Is Vertex Pharmaceuticals Incorporated stock ready for breakoutPortfolio Risk Report & Daily Growth Stock Investment Tips - ulpravda.ru
Wagner, Vertex Pharmaceuticals evp, sells $4.39m in VRTX stock - Investing.com
Vertex Pharmaceuticals Executive Sells Over $4 Million in Company Stock - TradingView — Track All Markets
Vertex Pharmaceuticals Inc Stock Price Live, Charts & News - The Economic Times
Is Vertex Pharmaceuticals Incorporated stock positioned well for digital economyTrade Entry Report & Technical Confirmation Alerts - ulpravda.ru
Vertex Advances Suzetrigine Phase 3 Trial in Diabetic Nerve Pain, Signaling a Broader Growth Story - TipRanks
Weekly Recap: How Vertex Pharmaceuticals Incorporated stock performs in rising dollar environment2025 Institutional Moves & Technical Pattern Recognition Alerts - ulpravda.ru
RBC Raises Price Target on Vertex Pharmaceuticals to $455 From $415, Keeps Sector Perform Rating - marketscreener.com
1.62%
1.74%
자본화:
|
볼륨(24시간):